British Journal of Clinical Pharmacology · 1989 · 64 citations · 21 references
MedicineBiochemistryPharmacologyChemotherapyDrug MetabolismHepatic PharmacokineticsAntifungal AgentsCytochrome P450 EnzymesDrug-metabolizing EnzymesEnzyme InhibitionHepatic Drug MetabolismIn Vitro Metabolic AssaysCytochrome P450 Enzyme ActivityCytochrome P450 Enzyme InhibitionCytochrome P450 Human Liver MicrosomesMetabolic Enzyme InhibitionMicrosomal Drug MetabolismMicrosomal Enzyme-mediated MetabolismMicrosomal Incubation AssaysTerbinafine Therapy
Two antimycotic agents, the azole ketoconazole and the allylamine terbinafine, have been examined for their effects on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes (n = 4) in vitro. Ketoconazole caused marked inhibition of all enzyme activities with mean IC50 values (concentration producing 50% inhibition) of 17.9 microM (tolbutamide hydroxylase), 1.9 microM (ethinyloestradiol 2-hydroxylase), 2.0 microM (cyclosporin N-demethylase), 2.1 microM (cyclosporin hydroxylase) and 25 microM (ethoxycoumarin O-deethylase). At 50 microM terbinafine concentration, inhibition was less than 5% for tolbutamide and ethoxycoumarin, approximately 12% for both cyclosporin pathways and 35% for ethinyloestradiol. Terbinafine does not have the same inhibitory potential for cytochrome P-450 isozymes as ketoconazole.
21
The Carbon Monoxide-binding Pigment of Liver Microsomes
Tsuneo Omura, Ryo Sato · Journal of Biological Chemistry · 1964 · 11.8K citations · Full text
William F. Greenlee, Alan Poland · Journal of Pharmacology and Experimental Therapeutics · 1978 · 624 citations
Medicine, Biochemistry, Pharmacology +17
Thomas Kronbach, Volker Fischer, Urs Meyer · Clinical Pharmacology & Therapeutics · 1988 · 539 citations
Medicine, Biochemistry, Pharmacology +17